DSC Advisors, L.P. - Q3 2013 holdings

$157 Million is the total value of DSC Advisors, L.P.'s 54 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 131.2% .

 Value Shares↓ Weighting
CAH BuyCARDINAL HEALTH INC$9,387,000
+297.8%
180,000
+260.0%
5.97%
+282.7%
URI BuyUNITED RENTALS INC$6,021,000
+169.9%
103,300
+13.1%
3.83%
+159.6%
TRN BuyTRINITY INDS INC$5,510,000
+43.3%
121,500
+21.5%
3.51%
+38.0%
ACLS BuyAXCELIS TECHNOLOGIES INC$4,115,000
+465.2%
1,950,000
+387.5%
2.62%
+443.4%
IGV BuyISHARES TRna tec-sftwr etf$3,926,000
+24.5%
51,467
+10.9%
2.50%
+19.8%
PLXT BuyPLX TECHNOLOGY INC$3,913,000
+174.0%
650,000
+116.7%
2.49%
+163.8%
NYT BuyNEW YORK TIMES COcl a$3,771,000
+152.6%
300,000
+122.2%
2.40%
+143.2%
BKD NewBROOKDALE SR LIVING INC$3,156,000120,000
+100.0%
2.01%
BPI NewBRIDGEPOINT ED INC$2,477,000137,300
+100.0%
1.58%
BR NewBROADRIDGE FINL SOLUTIONS IN$1,848,00058,207
+100.0%
1.18%
AMGN BuyAMGEN INC$1,679,000
+30.9%
15,000
+15.4%
1.07%
+25.9%
VHT BuyVANGUARD WORLD FDShealth car etf$1,671,000
+10.1%
17,944
+2.1%
1.06%
+5.9%
MRC NewMRC GLOBAL INC$1,608,00060,000
+100.0%
1.02%
ALKS NewALKERMES PLC$1,513,00045,000
+100.0%
0.96%
CERS NewCERUS CORP$1,342,000200,000
+100.0%
0.85%
CR NewCRANE CO$925,00015,000
+100.0%
0.59%
IWM BuyISHARESput$840,000
+250.0%
1,500,000
+650.0%
0.54%
+236.5%
NAVB BuyNAVIDEA BIOPHARMACEUTICALS I$795,000
+26.8%
300,000
+27.7%
0.51%
+21.9%
IYW BuyISHARES TRu.s. tech etf$513,000
+8.2%
6,508
+1.2%
0.33%
+3.8%
XNY BuyCHINA XINIYA FASHION LTDsponsored adr$508,000
+38.8%
400,000
+3.9%
0.32%
+33.5%
MRGE BuyMERGE HEALTHCARE INC$378,000
+62.2%
145,000
+124.4%
0.24%
+56.5%
XLI BuySELECT SECTOR SPDR TRsbi int-inds$296,000
+9.6%
6,383
+0.9%
0.19%
+5.0%
URI NewUNITED RENTALS INCcall$203,00070,000
+100.0%
0.13%
ACLS BuyAXCELIS TECHNOLOGIES INCcall$140,000
+1300.0%
700,000
+600.0%
0.09%
+1171.4%
GS NewGOLDMAN SACHS GROUP INCput$113,00025,000
+100.0%
0.07%
AVP NewAVON PRODS INCput$75,00050,000
+100.0%
0.05%
FDX NewFEDEX CORPput$73,00025,000
+100.0%
0.05%
NUAN NewNUANCE COMMUNICATIONS INCput$70,000100,000
+100.0%
0.04%
XRT NewSPDR SERIES TRUSTput$67,00050,000
+100.0%
0.04%
JNJ NewJOHNSON & JOHNSONput$39,00050,000
+100.0%
0.02%
SLV NewISHARES SILVER TRUSTput$36,00050,000
+100.0%
0.02%
MYGN NewMYRIAD GENETICS INCcall$14,00015,000
+100.0%
0.01%
MDR NewMCDERMOTT INTL INCcall$5,000100,000
+100.0%
0.00%
PBI NewPITNEY BOWES INCput$3,00050,000
+100.0%
0.00%
TRN NewTRINITY INDS INCput$2,00035,000
+100.0%
0.00%
ZNGA NewZYNGA INCput$2,000100,000
+100.0%
0.00%
BB NewBLACKBERRY LTDcall$1,00050,000
+100.0%
0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2013-11-19
  • View 13F-HR/A filed 2014-10-15
  • View 13F-HR/A filed 2014-11-18
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CVS HEALTH CORP39Q3 202321.2%
MICROSOFT CORP38Q3 20232.9%
APPLE INC37Q3 20232.7%
META PLATFORMS INC37Q3 20231.6%
UNITEDHEALTH GROUP INC37Q3 20221.5%
ORACLE CORP35Q3 20230.6%
INTERNATIONAL BUSINESS MACHS33Q3 20220.6%
ALPHABET INC32Q3 202316.0%
ALPHABET INC32Q3 20232.6%
SALESFORCE INC30Q3 20230.9%

View DSC Advisors, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
DSC Advisors, L.P. Q3 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
BioScrip, Inc.March 12, 20151,842,2412.7%
TARRAGON CORPSold outFebruary 25, 200900.0%
OGLEBAY NORTON CO /NEW/Sold outSeptember 29, 200600.0%
JORGENSEN EARLE M CO /DE/August 08, 20052,444,2005.0%
AFFIRMATIVE INSURANCE HOLDINGS INCJune 15, 20051,159,6997.8%
VESTA INSURANCE GROUP INCSold outDecember 30, 200400.0%
HANGER ORTHOPEDIC GROUP INCNovember 08, 20041,103,9005.1%

View DSC Advisors, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14

View DSC Advisors, L.P.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export DSC Advisors, L.P.'s holdings